255 related articles for article (PubMed ID: 37407818)
1. Therapy-induced APOBEC3A drives evolution of persistent cancer cells.
Isozaki H; Sakhtemani R; Abbasi A; Nikpour N; Stanzione M; Oh S; Langenbucher A; Monroe S; Su W; Cabanos HF; Siddiqui FM; Phan N; Jalili P; Timonina D; Bilton S; Gomez-Caraballo M; Archibald HL; Nangia V; Dionne K; Riley A; Lawlor M; Banwait MK; Cobb RG; Zou L; Dyson NJ; Ott CJ; Benes C; Getz G; Chan CS; Shaw AT; Gainor JF; Lin JJ; Sequist LV; Piotrowska Z; Yeap BY; Engelman JA; Lee JJ; Maruvka YE; Buisson R; Lawrence MS; Hata AN
Nature; 2023 Aug; 620(7973):393-401. PubMed ID: 37407818
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3A is a prominent cytidine deaminase in breast cancer.
Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
[TBL] [Abstract][Full Text] [Related]
3. APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability.
Kawale AS; Ran X; Patel PS; Saxena S; Lawrence MS; Zou L
Sci Adv; 2024 Jan; 10(3):eadk2771. PubMed ID: 38241374
[TBL] [Abstract][Full Text] [Related]
4. An impaired ubiquitin-proteasome system increases APOBEC3A abundance.
Coxon M; Dennis MA; Dananberg A; Collins CD; Wilson HE; Meekma J; Savenkova MI; Ng D; Osbron CA; Mertz TM; Goodman AG; Duttke SH; Maciejowski J; Roberts SA
NAR Cancer; 2023 Dec; 5(4):zcad058. PubMed ID: 38155930
[TBL] [Abstract][Full Text] [Related]
5. APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas.
Selenica P; Marra A; Choudhury NJ; Gazzo A; Falcon CJ; Patel J; Pei X; Zhu Y; Ng CKY; Curry M; Heller G; Zhang YK; Berger MF; Ladanyi M; Rudin CM; Chandarlapaty S; Lovly CM; Reis-Filho JS; Yu HA
Ann Oncol; 2022 Dec; 33(12):1284-1295. PubMed ID: 36089134
[TBL] [Abstract][Full Text] [Related]
6. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA
Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849
[TBL] [Abstract][Full Text] [Related]
7. Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity.
Green AM; DeWeerd RA; O'Leary DR; Hansen AR; Hayer KE; Kulej K; Dineen AS; Szeto JH; Garcia BA; Weitzman MD
EMBO Rep; 2021 Sep; 22(9):e52145. PubMed ID: 34347354
[TBL] [Abstract][Full Text] [Related]
8. Single-stranded DNA binding proteins influence APOBEC3A substrate preference.
Brown AL; Collins CD; Thompson S; Coxon M; Mertz TM; Roberts SA
Sci Rep; 2021 Oct; 11(1):21008. PubMed ID: 34697369
[TBL] [Abstract][Full Text] [Related]
9. Orthologous mammalian APOBEC3A cytidine deaminases hypermutate nuclear DNA.
Caval V; Suspène R; Vartanian JP; Wain-Hobson S
Mol Biol Evol; 2014 Feb; 31(2):330-40. PubMed ID: 24162735
[TBL] [Abstract][Full Text] [Related]
10. Unraveling the Enzyme-Substrate Properties for APOBEC3A-Mediated RNA Editing.
Kim K; Shi AB; Kelley K; Chen XS
J Mol Biol; 2023 Sep; 435(17):168198. PubMed ID: 37442413
[TBL] [Abstract][Full Text] [Related]
11. HPV11 E6 mutation by overexpression of APOBEC3A and effects of interferon-ω on APOBEC3s and HPV11 E6 expression in HPV11.HaCaT cells.
Wang Y; Li X; Song S; Sun Y; Zhang J; Yu C; Chen W
Virol J; 2017 Nov; 14(1):211. PubMed ID: 29100527
[TBL] [Abstract][Full Text] [Related]
12. Cytidine deaminase Apobec3a induction in fallopian epithelium after exposure to follicular fluid.
Brachova P; Alvarez NS; Van Voorhis BJ; Christenson LK
Gynecol Oncol; 2017 Jun; 145(3):577-583. PubMed ID: 28215840
[TBL] [Abstract][Full Text] [Related]
13. Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment.
Vural S; Simon R; Krushkal J
Hum Genomics; 2018 Apr; 12(1):20. PubMed ID: 29642934
[TBL] [Abstract][Full Text] [Related]
14. Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome.
Nakata Y; Ode H; Kubota M; Kasahara T; Matsuoka K; Sugimoto A; Imahashi M; Yokomaku Y; Iwatani Y
Nucleic Acids Res; 2023 Jan; 51(2):783-795. PubMed ID: 36610792
[TBL] [Abstract][Full Text] [Related]
15. Creating RNA Specific C-to-U Editase from APOBEC3A by Separation of Its Activities on DNA and RNA Substrates.
Tang G; Xie B; Hong X; Qin H; Wang J; Huang H; Hao P; Li X
ACS Synth Biol; 2021 May; 10(5):1106-1115. PubMed ID: 33938211
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme.
Caval V; Bouzidi MS; Suspène R; Laude H; Dumargne MC; Bashamboo A; Krey T; Vartanian JP; Wain-Hobson S
Nucleic Acids Res; 2015 Oct; 43(19):9340-9. PubMed ID: 26384561
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.
Westrich JA; Warren CJ; Klausner MJ; Guo K; Liu CW; Santiago ML; Pyeon D
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367246
[TBL] [Abstract][Full Text] [Related]
18. Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.
Narvaiza I; Linfesty DC; Greener BN; Hakata Y; Pintel DJ; Logue E; Landau NR; Weitzman MD
PLoS Pathog; 2009 May; 5(5):e1000439. PubMed ID: 19461882
[TBL] [Abstract][Full Text] [Related]
19. Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions.
Henry M; Terzian C; Peeters M; Wain-Hobson S; Vartanian JP
PLoS One; 2012; 7(1):e30036. PubMed ID: 22272271
[TBL] [Abstract][Full Text] [Related]
20. Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A.
Aynaud MM; Suspène R; Vidalain PO; Mussil B; Guétard D; Tangy F; Wain-Hobson S; Vartanian JP
J Biol Chem; 2012 Nov; 287(46):39182-92. PubMed ID: 22977230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
